Gemcitabine plus Oxaliplatin (GEMOX) in Pretreated Patients with Advanced Ovarian Cancer : A Multicenter Phase II Study of the Hellenic Oncology Research Group (HORG)KALYKAU, Antonia; PAPAKOTOULAS, Pavlos; MAVROUDIS, Dimitris et al.Anticancer research. 2008, Vol 28, Num 1B, pp 495-500, issn 0250-7005, 6 p.Article

Sequential combination of paclitaxel-carboplatin and paclitaxel-liposomal doxorubicin as a first- line treatment in patients with ovarian cancer : A multicenter phase II trialPOTAMIANOU, Anna; ANDROULAKIS, Nikolaos; PAPAKOTOULAS, Pavlos et al.Oncology. 2005, Vol 69, Num 4, pp 348-353, issn 0030-2414, 6 p.Article

Platinum-based chemotherapy with thoracic radiotherapy in stage III good performance status non-small cell lung cancer patientsBAKA, Sofia; FAIVRE-FINN, Corinne; PAPAKOTOULAS, Pavlos et al.European journal of cancer. Supplement (1990). 2005, Vol 3, Num 3, pp 41-50, issn 1359-6349, 10 p.Conference Paper

Gemcitabine plus oxaliplatin combination (GEMOX regimen) in pretreated patients with advanced non-small cell lung cancer (NSCLC) : A multicenter phase II studyKAKOLYRIS, Stylianos; ZIRAS, Nikolaos; VAMVAKAS, Lambros et al.Lung cancer. 2006, Vol 54, Num 3, pp 347-352, issn 0169-5002, 6 p.Article

Phase III Study Comparing Sequential Versus Alternate Administration of Cisplatin-Etoposide and Topotecan as First-line Treatment in Small Cell Lung CancerBAKA, Sophia; AGELAKI, Sophia; ANDROULAKIS, Nikolaos et al.Anticancer research. 2010, Vol 30, Num 7, pp 3031-3038, issn 0250-7005, 8 p.Article

A multicenter phase II study of sequential vinorelbine and cisplatin followed by docetaxel and gemcitabine in patients with advanced non-small cell lung cancerPALLIS, Athanasios G; AGELIDOU, Athina; KENTEPOZIDIS, Nikolaos et al.Lung cancer. 2006, Vol 52, Num 2, pp 165-171, issn 0169-5002, 7 p.Article

A multicenter phase II study of the combination of gemcitabine and docetaxel in previously treated patients with small cell lung cancerAGELAKI, Sofia; VESLEMES, Marinos; VAMVAKAS, Lambros et al.Lung cancer. 2004, Vol 43, Num 3, pp 329-333, issn 0169-5002, 5 p.Article

Docetaxel versus docetaxel plus cisplatin as front-line treatment of patients with advanced non-small-cell lung cancer: A randomized, multicenter phase III trialGEORGOULIAS, Vassilis; ARDAVANIS, Alexandros; SAMARAS, Nikolaos et al.Journal of clinical oncology. 2004, Vol 22, Num 13, pp 2602-2609, issn 0732-183X, 8 p.Article

Pemetrexed Versus Erlotinib in Pretreated Patients With Advanced Non-Small Cell Lung Cancer: A Hellenic Oncology Research Group (HORG) Randomized Phase 3 StudyKARAMPEAZIS, Athanasios; VOUTSINA, Alexandra; AGELAKI, Sofia et al.Cancer. 2013, Vol 119, Num 15, pp 2754-2764, issn 0008-543X, 11 p.Article

FEC versus sequential docetaxel followed by epirubicin/ cyclophosphamide as adjuvant chemotherapy in women with axillary node-positive early breast cancer: a randomized study of the Hellenic Oncology Research Group (HORG)POLYZOS, Aristides; MALAMOS, Nikolaos; KARVOUNIS, Nikolaos et al.Breast cancer research and treatment. 2010, Vol 119, Num 1, pp 95-104, issn 0167-6806, 10 p.Article

A multicenter randomized phase II study of the irinotecan/gemcitabine doublet versus irinotecan monotherapy in previously treated patients with extensive stage small-cell lung cancerPALLIS, Athanasios G; AGELIDOU, Athina; GEORGOULIAS, Vassilis et al.Lung cancer. 2009, Vol 65, Num 2, pp 187-191, issn 0169-5002, 5 p.Article

Chemotherapy with gemcitabine, cisplatin, and docetaxel in the treatment for patients with muscle-invasive bladder cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG)BOUKOVINAS, Ioannis; ANDROULAKIS, Nikolaos; KOSTAKOPOULOS, Athanasios et al.Cancer chemotherapy and pharmacology. 2012, Vol 69, Num 2, pp 351-356, issn 0344-5704, 6 p.Article